Joseph, Kevin
Joseph, Kevin was paid $212K by Medicaid between Jan 2018 and Dec 2024, across 23 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 69% of everything it billed.
33Billing provider infoJOSEPH, KEVIN
PALOS HEIGHTS, IL 60463
PALOS HEIGHTS, IL 60463
33aNPI1932441771assigned 03/19/2013
33bProvider typeStudent in an Organized Health Care Education/Training Program
28Total paid$212K
24GClaims10,383
24DCodes billed23
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Student in an Organized Health Care Education/Training Program providers in Illinois
Rank by total paid#117 of 981
Median peer was paid$27K
This provider vs. median8.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 318 | $14K | |
| 2019 | 551 | $18K | |
| 2020 | 1,779 | $24K | |
| 2021 | 2,512 | $49K | |
| 2022 | 2,283 | $49K | |
| 2023 | 1,332 | $25K | |
| 2024incomplete | 1,608 | $35K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 69% | 3,008 | 2,580 | $146K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 8.1% | 336 | 241 | $17K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 5.4% | 145 | 136 | $11K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 3.9% | 353 | 317 | $8K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 3.3% | 154 | 132 | $7K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 3.1% | 94 | 83 | $7K |
| 87428 | 2.7% | 89 | 82 | $6K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 1.8% | 54 | 41 | $4K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 1.2% | 33 | 27 | $3K |
| 87999 | <1% | 101 | 99 | $2K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 15 | 13 | $469.50 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 25 | 24 | $377.95 |
11 more codes
| 90698 | <1% | 36 | $230.40 | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 12 | $192.84 |
| 96127 | <1% | 12 | $175.20 | |
| 90670 | <1% | 12 | $76.80 | |
| 3074F | 0% | 966 | $0.00 | |
| 1159F | 0% | 1,892 | $0.00 | |
| 1160F | 0% | 1,892 | $0.00 | |
| 3078F | 0% | 887 | $0.00 | |
| 3210F | 0% | 25 | $0.00 | |
| 99072 | 0% | 207 | $0.00 | |
| 1003F | 0% | 35 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.